These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16917105)

  • 1. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.
    Ng VY; Morisseau C; Falck JR; Hammock BD; Kroetz DL
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2462-8. PubMed ID: 16917105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
    Fang X; Hu S; Watanabe T; Weintraub NL; Snyder GD; Yao J; Liu Y; Shyy JY; Hammock BD; Spector AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):260-70. PubMed ID: 15798002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
    Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
    Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
    Gizard F; Nomiyama T; Zhao Y; Findeisen HM; Heywood EB; Jones KL; Staels B; Bruemmer D
    Circ Res; 2008 Nov; 103(10):1155-63. PubMed ID: 18818403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.
    Davis BB; Morisseau C; Newman JW; Pedersen TL; Hammock BD; Weiss RH
    J Pharmacol Exp Ther; 2006 Feb; 316(2):815-21. PubMed ID: 16221742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.
    Chang NW; Wu CT; Chen DR; Yeh CY; Lin C
    J Nutr Biochem; 2013 Jan; 24(1):274-81. PubMed ID: 22902323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.
    Davis BB; Thompson DA; Howard LL; Morisseau C; Hammock BD; Weiss RH
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2222-7. PubMed ID: 11842228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
    Gizard F; Amant C; Barbier O; Bellosta S; Robillard R; Percevault F; Sevestre H; Krimpenfort P; Corsini A; Rochette J; Glineur C; Fruchart JC; Torpier G; Staels B
    J Clin Invest; 2005 Nov; 115(11):3228-38. PubMed ID: 16239970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The fibrate-activated PPARalpha/p16INK4A pathway inhibits vascular smooth muscle cell proliferation and vascular occlusion].
    Gizard F; Staels B
    Med Sci (Paris); 2006 Apr; 22(4):351-3. PubMed ID: 16597398
    [No Abstract]   [Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
    Zahradka P; Wright B; Fuerst M; Yurkova N; Molnar K; Taylor CG
    J Pharmacol Exp Ther; 2006 May; 317(2):651-9. PubMed ID: 16407462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
    Benson SC; Iguchi R; Ho CI; Yamamoto K; Kurtz TW
    J Hypertens; 2008 May; 26(5):973-80. PubMed ID: 18398340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.
    Schachtrup C; Emmler T; Bleck B; Sandqvist A; Spener F
    Biochem J; 2004 Aug; 382(Pt 1):239-45. PubMed ID: 15130092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
    Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
    Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A(3) receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes.
    Hinze AV; Mayer P; Harst A; von Kügelgen I
    J Mol Cell Cardiol; 2012 Nov; 53(5):639-45. PubMed ID: 22906537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclin D1 is involved in human pulmonary artery smooth muscle cells proliferation and migration induced by cigarette smoke extract].
    Xiang M; Xu YJ; Liu XS; Zeng DX
    Sheng Li Xue Bao; 2010 Apr; 62(2):156-62. PubMed ID: 20401451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ.
    Manea A; Manea SA; Todirita A; Albulescu IC; Raicu M; Sasson S; Simionescu M
    Cell Tissue Res; 2015 Aug; 361(2):593-604. PubMed ID: 25722086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor ɑ (PPARɑ)-cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2- breast cancer.
    Tauber Z; Koleckova M; Cizkova K
    Med Mol Morphol; 2020 Sep; 53(3):141-148. PubMed ID: 31823010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.